Hospital variability in postoperative mortality after rectal cancer surgery in the Spanish Association of Surgeons project: The impact of hospital volume.
Ortiz H, Biondo S, Codina A, Ciga MÁ, Enríquez-Navascués JM, Espín E, García-Granero E, Roig JV.
Cirugia Española. 2016; 94: 22-30. FI: 1,276 (Q3).
Treatment of anastomotic leaks with metallic stent after esophagectomies.
Eizaguirre E, Larburu S, Asensio JI, Rodriguez A, Elorza JL, Loyola F, Urdapilleta G, Navascués JM.
Dis Esophagus. 2016; 29: 86-92. FI: 2,571 (Q3).
IV Spanish Consensus Conference on Helicobacter pylori infection treatment.
Gisbert JP, Molina-Infante J, Amador J, Bermejo F, Bujanda L, Calvet X, Castro-Fernández M, Cuadrado-Lavín A, Elizalde JI, Gene E, Gomollón F, Lanas Á, Martín de Argila C, Mearin F, Montoro M, Pérez-Aisa Á, Pérez-Trallero E, McNicholl AG.
Gastroenterologia Y Hepatologia. 2016; 39: 697-721. FI: 0,917 (Q4).
p-21 activated kinase 4 (PAK4) role in pancreatic cancer stem cells.
Herreros-Villanueva M, Bujanda L.
Translational Cancer Research. 2016; 5: 335-337. FI: 1,167 (Q4).
Anal intraepitelial neoplasia: A narrative review.
Elorza G, Saralegui Y, Enríquez-Navascués JM, Placer C, Velaz L.
Revista Española De Enfermedades Digestivas. 2016; 108: 31-39. FI: 1,401 (Q4).
Effect of hospital caseload on long-term outcome after standardization of rectal cancer surgery in the Spanish Rectal Cancer Project.
Ortiz H, Codina A, Ciga MÁ, Biondo S, Enríquez-Navascués JM, Espín E, García-Granero E, Roig JV.
Cirugia Española. 2016; 94: 442-452. FI: 1,276 (Q3).
Hospital variation in anastomotic leakage after rectal cancer surgery in the Spanish Association of Surgeons project: The contribution of hospital volume.
Ortiz H, Biondo S, Codina A, Ciga MÁ, Enríquez-Navascués J, Espín E, García-Granero E, Roig JV.
Cirugia Española. 2016; 94: 213-220. FI: 1,276 (Q3).
Incidence and characterization of the anterior resection syndrome through the use of the LARS scale (low anterior resection score).
Carrillo A, Enríquez-Navascués JM, Rodríguez A, Placer C, Múgica JA, Saralegui Y, Timoteo A, Borda N.
Cirugia Española. 2016; 94: 137-143. FI: 1,276 (Q3).
MicroRNAs in cholangiopathies: Potential diagnostic and therapeutic tools.
Esparza-Baquer A, Labiano I, Bujanda L, Perugorria MJ, Banales JM.
Clinics And Research In Hepatology And Gastroenterology. 2016; 40: 15-27. FI: 2,323 (Q3).
NLRP3 inflammasome activation by microbial products leads to IL-18 synthesis and impaired epithelial barrier function in cholangiocytes.
Maroni L, Agostinelli L, Saccomanno S, Mingarelli E, Rychlicki C, De Minicis S, Banales JM, Benedetti A, Baroni GS, Marzioni M.
Digestive And Liver Disease. 2016; 48: 12-12. FI: 3,061 (Q2).
Antimicrobial Susceptibility-Guided Therapy Versus Empirical Concomitant Therapy for Eradication of Helicobacter pylori in a Region with High Rate of Clarithromycin Resistance.
Cosme A, Lizasoan J, Montes M, Tamayo E, Alonso H, Mendarte U, Martos M, Fernández-Reyes M, Saraqueta C, Bujanda L.
Helicobacter. 2016; 21: 29-34. FI: 3,429 (Q2).
Mechanisms of Resistance to Chemotherapy in Gastric Cancer.
Marin JJ, Al-Abdulla R, Lozano E, Briz O, Bujanda L, Banales JM, Macias RI.
Anti-Cancer Agents In Medicinal Chemistry. 2016; 16: 318-334. FI: 2,598 (Q2).
Bile Acids in Physiology, Pathology and Pharmacology.
Marin JJ, Macias IR, Briz O, Banales JM, Monte MJ.
Current Drug Metabolism. 2016; 17: 4-29. FI: 2,659 (Q2).
“Fast track” and intestinal surgery for Crohn’s disease: Factors associated with prolonged hospital stay.
Enriquez-Navascués JM, Elorza G, Placer C, Timoteo A, Velaz L, Borda N, Saralegui Y.
Cirugia Española. 2016; 94: 531-536. FI: 1,276 (Q3).
